[Sudden cessation of psychotropic drugs].
D000293:Adolescent; D000328:Adult; D000639:Amitriptyline / Q000009:adverse effects; D000928:Antidepressive Agents / Q000097:blood*; D001714:Bipolar Disorder / Q000188:drug therapy*; D001794:Blood Pressure; D002746:Chlorpromazine / Q000009:adverse effects; D004569:Electroencephalography; D004837:Epinephrine / Q000097:blood; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D005712:Galvanic Skin Response; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D007099:Imipramine / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009129:Muscle Tonus; D010546:Perphenazine / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D005082:Physical Exertion; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D012701:Serotonin / Q000097:blood; D013375:Substance Withdrawal Syndrome; D013577:Syndrome; D014149:Tranquilizing Agents / Q000009:adverse effects*; D014268:Trifluoperazine / Q000009:adverse effects; D014272:Trifluperidol / Q000009:adverse effects
D000928:Antidepressive Agents; D010640:Phenothiazines; D014149:Tranquilizing Agents; D000639:Amitriptyline; D014268:Trifluoperazine; D012701:Serotonin; D010546:Perphenazine; D006220:Haloperidol; D007099:Imipramine; D014272:Trifluperidol; D005476:Fluphenazine; D002746:Chlorpromazine; D004837:Epinephrine
Vnezapnaia otmena psikhotropnykh sredstv